Ensuring safe handling of clinical materials for COVID-19 research
Division of Microbiology and Infectious Diseases (DMID): Clinical Materials Services (CMS), SARS-CoV-2
This study is all about making sure that the materials used in COVID-19 research are handled safely and correctly, which helps improve the quality of clinical trials that could benefit patients like you in the fight against the virus.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fisher Bioservices, INC. NIH-funded |
| Lab location | 1 site (Rockville, United States) |
| Project ID | NIH-11179076 on NIH RePORTER |
What this research studies
This research focuses on maintaining high standards for the handling of clinical materials related to SARS-CoV-2, ensuring that all processes meet Good Manufacturing Practice (cGMP), Good Clinical Practice (GCP), and Good Laboratory Practice (GLP) guidelines. It involves the acquisition, receipt, storage, and shipping of clinical agents and specimens to support clinical trials and research programs aimed at understanding and combating COVID-19. Patients may benefit indirectly through improved research quality and outcomes in clinical trials related to COVID-19.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals involved in clinical trials for COVID-19 treatments or vaccines.
Not a fit: Patients who are not participating in clinical trials or are not affected by COVID-19 may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could enhance the reliability and safety of clinical trials for COVID-19 treatments and vaccines.
How similar studies have performed: Other research has shown success in improving clinical trial outcomes through adherence to stringent manufacturing and clinical practices.
Where this research is happening
Rockville, United States
- Fisher Bioservices, INC. — Rockville, United States (Active)
Researchers
- Principal investigator: Eyler, Dennis — Fisher Bioservices, INC.
- Study coordinator: Eyler, Dennis
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.